Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Aomeihua Pharmaceutical is a specialized pharmaceutical company based in Haikou, China, that focuses on the research, development, and large-scale production of chemical drugs. Established in 2001, the company has built a robust portfolio centered on therapeutic areas such as cardiovascular disease, gastroenterology, and anti-infectives. Its manufacturing facilities are equipped with multiple GMP-certified production lines capable of producing various dosage forms, including tablets, capsules, and both large and small-volume injections. As a recognized high-tech enterprise in Hainan Province, the company emphasizes quality control and technological innovation in the generic drug space. Hainan Aomeihua serves a broad domestic market and continues to expand its reach through a comprehensive distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Aomeihua Pharmaceutical.